Data / Form D filings / Iverson Genetic Diagnostics Inc
Iverson Genetic Diagnostics Inc: Form D filings
Iverson Genetic Diagnostics Inc, a biotechnology company in Seattle, WA, filed 9 Form D notices with the SEC between 2010 and 2014. The latest, on October 9, 2014, reports $20,000 sold of a $5 million offering to 1 investor.
Find out what Iverson Genetic Diagnostics Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 401 Terry Avenue North, Seattle, WA, 98109
- Phone
- (206) 946-6000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1417699
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 9, 2014 | New notice | $5,000,000 | $20,000 | $4,980,000 | 1 | Oct 7, 2014 | sec.gov |
| Dec 16, 2013 | New notice | $3,000,000 | $0 | $3,000,000 | 0 | Yet to occur | sec.gov |
| Nov 26, 2012 | New notice | $1,000,000 | $42,500 | $957,500 | 3 | Nov 1, 2012 | sec.gov |
| Dec 5, 2011 | Amendment | $2,000,000 | $115,000 | $1,885,000 | 2 | Nov 1, 2011 | sec.gov |
| Dec 2, 2011 | New notice | $2,000,000 | $50,000 | $1,950,000 | 1 | Nov 30, 2011 | sec.gov |
| Jul 22, 2011 | New notice | $9,000,000 | $75,000 | $8,925,000 | 3 | Jul 18, 2011 | sec.gov |
| May 14, 2010 | New notice | $8,000,000 | $110,000 | $7,890,000 | 4 | Apr 28, 2010 | sec.gov |
| Mar 30, 2010 | New notice | $3,000,000 | $110,000 | $2,890,000 | 2 | Mar 9, 2010 | sec.gov |
| Feb 2, 2010 | New notice | $700,000 | $341,000 | $359,000 | 13 | Nov 25, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Yelena Shevelenko | Executive Officer | |
| Doranne Satterlee | Director | |
| Tom Siggia | Director | |
| David C Michaels | Director | |
| Dean Sproles | Director | |
| Harvey Schiller | Director | |
| Jeff Nyweide | Executive Officer |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Oct 6, 2014 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Iverson Genetic Diagnostics Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.